Richard Scheller
23andMe assigns chief scientific officer to new unit
March 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 23andm3, Richard Scheller
US personal genetics firm 23andMe has created a new therapeutics group and appointed pharma veteran Richard Scheller as chief science …
Latest content
MedPharm appoints Jason Mieding as chief operating officer
November 8, 2026
Coriolis Pharma appoints Teun van der Heide as CEO
November 7, 2026
